Vasculitis: Diagnosis and therapy

American Journal of Medicine

Volumn 100, Issue 2 A, 1996, Pages 37S-45S

  Hunder, Gene ^a,b  

^a MAYO CLINIC COLLEGE OF MEDICINE   (United States)

^b MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AORTA ARCH SYNDROME; AORTOGRAPHY; BIOPSY; CLINICAL FEATURE; CONFERENCE PAPER; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; GIANT CELL ARTERITIS; HUMAN; PHYSICAL EXAMINATION; POLYARTERITIS NODOSA; PRIORITY JOURNAL; RHEUMATIC DISEASE; RHEUMATIC POLYMYALGIA; VASCULITIS; WEGENER GRANULOMATOSIS; CLASSIFICATION; DRUG MONITORING; REVIEW; SYNDROME;

DRUG MONITORING; HUMANS; RHEUMATIC DISEASES; SYNDROME; VASCULITIS;

EID: 84948740348     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0002-9343(97)89545-9     Document Type: Conference Paper

References (29)

1. Lie JT. Diagnostic histopathology of major systemic and pulmonary vasculitic syndromes. Rheum Dis Clin North Am. 1990;16:269-292.
2. Kerr GS, Hallahan CW, Giordano J, et al. Takayasu arteritis. Ann Intern Med. 1994;120:919-929.
3. Sunday JS, Haynes BF. Pathogenic mechanisms of vessel damage in vasculitis syndromes. Rheum Dis Clin North Am. 1995;21:861-881.
4. van Vollenhoven RF. Adhesion molecules, sex steroids, and the pathogenesis of vasculitis syndromes. Curr Opinion Rheumatol. 1995;7:4-10.
5. Weyand CM, Goronzy JI. Molecular approaches toward pathologic mechanisms in giant cell arteritis and Takayasu's arteritis. Curr Opin Rheumatol. 1995;7:30-36.
6. Carson CW, Conn DL, Czaja AJ, Wright TL, Brecher ME. Frequency and significance of antibodies to hepatitis C virus in polyarteritis nodosa. J Rheumatol. 1993;20:304-309.
7. Quint L, Deny P, Guillevin L, et al. Hepatitis C virus in patients with polyarteritis nodosa: prevalence in 38 patients. Clin Exp Rheumatol. 1991;9:253-257.
8. Salvarani C, Gabriel SE, O'Fallon WM, Hunder GG. The incidence of giant cell arteritis in Olmsted County, Minnesota. Apparent fluctuation in a cyclic pattern. Ann Intern Med. 1995;123:192-194.
9. Hall S, Persellin S, Lie JT, et al. The therapeutic impact of temporal artery biopsy. Lancet. 1983;ii:1217-1220.
10. Calamia KT, Hunder GG. Clinical manifestations of giant cell (temporal) arteritis. Clin Rheum Dis. 1980;6:389-403.
11. Hunder GG. Giant cell (temporal) arteritis. Rheum Dis Clin North Am. 1990;16:399-409.
12. Aiello PD, Trautmann JC, McPhee J, et al. Visual prognosis in giant cell arteritis. Ophthalmology. 1993;100:550-555.
13. Hellmann DB. Immunopathogenesis, diagnosis, and treatment of giant cell arteritis, polymyalgia rheumatica, and Takayasu's arteritis. Curr Opin Rheumatol. 1993;5:25-32.
14. Evans JM, Bowles CA, Bjornsson B, Mullany CJ, Hunder GG. Thoracic aortic aneurysm and rupture in giant cell arteritis. Arthritis Rheum. 1994;37:1539-1547.
15. Michet CJ. Epidemiology of vasculitis. Rheum Dis Clin North Am. 1990;16:261-268.
16. Misiani R, Bellavita P, Fenili D, et al. Interferon alfa-2a therapy in cryoglobulinemia associated with hepatitis C virus. N Engl J Med. 1994;330:751-756.
17. Scott DGI, Bacon PA, Elliott PJ, Tribe CR, Wallingtone TB. Systemic vasculitis in a district general hospital 1972-1980: clinical and laboratory features, classification and prognosis of 80 cases. QJ Med. 1982;203:292-311.
18. Hoffman GS, Kerr GS, Leavitt RY, et al. Wegener's granulomatosis: an analysis of 158 patients. Ann Intern Med. 1992;116:488-498.
19. Nölle B, Specks U, Lüdemann J, et al. Anticytoplasmic autoantibodies: their immunodiagnostic value in Wegener granulomatosis. Ann Intern Med. 1989;11:28-40.
20. Gross WL, Schmitt WH, Csernok E. ANCA and associated diseases: immunodiagnostic and pathogenetic aspects. Clin Exp Immunol. 1993;91:1-12.
21. Specks U, Homburger HA. Laboratory medicine and pathology. Anti-neutrophil cytoplasmic antibodies. Mayo Clin Proc. 1994;69:1197-1198.
22. Gordon M, Luqmani RA, Adu D, et al. Relapses in patients with systemic vasculitis. QJ Med. 1993;86:779-789.
23. Hunder GG, Arend WP, Block DA, et al. The American College of Rheumatology 1990 criteria for the classification of vasculitis. Arthritis Rheum. 1990;33:1065-1067.
24. Hoffman GS, Leavitt RY, Kerr GS, Fauci AS. The treatment of Wegener's granulomatosis with glucocorticoids and methotrexate. Arthritis Rheum. 1992;35:1322-1329.
25. Sundel RP, Burns JC, Baker A, Beiser AS, Newburger JW. Gamma globulin retreatment in Kawasaki disease. J Pediatr. 1993;123:657-659.
26. Andersson R, Malmvall B-E, Bengtsson B-A. Long-term survival in giant cell arteritis including temporal arteritis and polymyalgia rheumatica. Acta Med Scand. 1986;220:361-364.
27. Guillevin L, Lê Thi Huong D, Godeau P, et al. Clinical findings and prognosis of polyarteritis nodosa and Churg-Strauss angiitis: a study in 165 patients. Br J Rheumatol. 1988;27:258-264.
28. Matheson EL, Gold KN, Block DA, et al. Long term survival of patients with Wegener's granulomatosis from the American College of Rheumatology Wegener's Granulomatosis Classification Criteria Cohort. Submitted for publication.
29. Haynes BF. Vasculitis: pathogenic mechanisms of vessel damage. In: Gallin JI, Goldstein IM, Snyderman R, eds. Inflammation: Basic Principles and Clinical Correlates. New York: Raven Press, 1992:921-941.